Abstract
The transforming growth factor-β (TGF-β) superfamily includes TGF-β s, activin, myostatin and bone morphogenetic proteins. Misregulation of the activity of TGF-β family members is involved in pathogenesis of cancer, muscular dystrophy, obesity and bone and tooth remodeling. Natural inhibitors for the TGF-β superfamily regulate fine-tuning of activity of TGF-β family in vivo. In addition to natural inhibitors for the TGF-β family, soluble forms of receptors for the TGF-β family, blocking monoclonal antibodies and small chemical TGF-β inhibitors have been developed. In this review, we summarize recent advances in our understanding of inhibitors for the TGF-β superfamily and their medical applications.
Original language | English |
---|---|
Pages (from-to) | 1255-1261 |
Number of pages | 7 |
Journal | Mini-Reviews in Medicinal Chemistry |
Volume | 6 |
Issue number | 11 |
DOIs | |
Publication status | Published - 11-2006 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Pharmacology
- Drug Discovery
- Cancer Research